1.A Case in which Botulinum Toxin was Effective for Palliative Care of Multiple System Atrophy
Daiki Kikuchi ; Hironobu Itou ; Yoshihiro Ogawa ; Satomi Kasai ; Ken Kikuchi ; Kiyoshi Sawauchi ; Naoko Yamada ; Setsuko Nakamura ; Izumi Yamato
An Official Journal of the Japan Primary Care Association 2016;39(3):163-165
2.Assessment of the Latent Adverse Events of Antipsychotic Treatment Using a Subjective Questionnaire in Japanese Patients with Schizophrenia.
Masakazu HATANO ; Hiroyuki KAMEI ; Azusa KATO ; Ippei TAKEUCHI ; Manako HANYA ; Junji UNO ; Shigeki YAMADA ; Kiyoshi FUJITA ; Nakao IWATA
Clinical Psychopharmacology and Neuroscience 2017;15(2):132-137
OBJECTIVE: The adverse effects of antipsychotic agents can have a marked influence on medication adherence. In this study, we investigated the adverse events of antipsychotics that are less likely to be reported by patients and the reasons why such symptoms remain latent. METHODS: Data were collected by interviewing patients using a subjective questionnaire, and the associations between unreported symptoms and background factors were investigated. RESULTS: A total of 306 patients with schizophrenia or schizoaffective disorder were examined. Their major symptoms were daytime sleepiness (50.0%), weight gain (42.2%), and sexual dysfunction (38.9%). Sexual dysfunction was nominal significantly more common among the patients that had been treated with antipsychotic agent polypharmacy (odds ratio [OR], 2.14; 95% confidence interval [CI], 1.07 to 4.30), and was nominal significantly more common among outpatients (OR, 1.78; 95% CI, 1.02 to 3.13). Only approximately 30% of the patients had reported their symptoms to their physicians. CONCLUSION: Patients receiving antipsychotic treatment tolerate some symptoms and do not feel able to report them to their physicians. The most common reason for this is an insufficient patient-physician relationship. Sexual dysfunction is especially hard to identify because it is a delicate problem, and our findings demonstrate that subjective questionnaires are helpful for detecting such symptoms.
Antipsychotic Agents
;
Asian Continental Ancestry Group*
;
Drug-Related Side Effects and Adverse Reactions
;
Humans
;
Medication Adherence
;
Outpatients
;
Polypharmacy
;
Psychotic Disorders
;
Schizophrenia*
;
Surveys and Questionnaires
;
Weight Gain
3.Evaluation of the Microvascular Research Center Training Program for Assessing Microsurgical Skills in Trainee Surgeons.
Seiji KOMATSU ; Kiyoshi YAMADA ; Shuji YAMASHITA ; Narushi SUGIYAMA ; Eijiro TOKUYAMA ; Kumiko MATSUMOTO ; Ayumi TAKARA ; Yoshihiro KIMATA
Archives of Plastic Surgery 2013;40(3):214-219
BACKGROUND: We established the Microvascular Research Center Training Program (MRCP) to help trainee surgeons acquire and develop microsurgical skills. Medical students were recruited to undergo the MRCP to assess the effectiveness of the MRCP for trainee surgeons. METHODS: Twenty-two medical students with no prior microsurgical experience, who completed the course from 2005 to 2012, were included. The MRCP comprises 5 stages of training, each with specific passing requirements. Stages 1 and 2 involve anastomosing silicone tubes and blood vessels of chicken carcasses, respectively, within 20 minutes. Stage 3 involves anastomosing the femoral artery and vein of live rats with a 1-day patency rate of >80%. Stage 4 requires replantation of free superficial inferior epigastric artery flaps in rats with a 7-day success rate of >80%. Stage 5 involves successful completion of one case of rat replantation/transplantation. We calculated the passing rate for each stage and recorded the number of anastomoses required to pass stages 3 and 4. RESULTS: The passing rates were 100% (22/22) for stages 1 and 2, 86.4% (19/22) for stage 3, 59.1% (13/22) for stage 4, and 55.0% (11/20) for stage 5. The number of anastomoses performed was 17.2+/-12.2 in stage 3 and 11.3+/-8.1 in stage 4. CONCLUSIONS: Majority of the medical students who undertook the MRCP acquired basic microsurgical skills. Thus, we conclude that the MRCP is an effective microsurgery training program for trainee surgeons.
Animals
;
Blood Vessels
;
Chickens
;
Epigastric Arteries
;
Femoral Artery
;
Humans
;
Microsurgery
;
Program Evaluation
;
Rats
;
Replantation
;
Silicones
;
Students, Medical
;
Tissue Transplantation
;
Veins
4.Effect on Undergraduate Medical Students of Exposure to a Summer Camp for Children with Asthma.
Shigemi YOSHIHARA ; Toshio ABE ; Yumi YAMADA ; Makoto WATANABE ; Mika ONO ; Mariko OYAMA ; Sanae KANAZAWA ; Michio NUMATA ; Kiyoshi NISHIKURA ; Daisuke NAKAJIMA ; Megumi HOSHI ; Norimasa FUKUDA ; Tamotsu ANDO ; Noriko KANNO ; Osamu ARISAKA ; Mitsuoki EGUCHI
Medical Education 2001;32(1):39-45
We investigated the effects on medical education of early exposure of undergraduate students to a summer camp for children with asthma. An objective evaluation by the editorial staff found final improvements in the following areas (in descending order of frequency): learning of basic medical behavior (91% of students); cooperative attitude of medical staff in general treatment with the patient and the patient's family (88%); understanding of childhood growth and development (80%); knowledge of childhood asthma (69%); and mastery of basic techniques for therapy and examination (41%). The differences in the ratio of improvement (%) before and after visiting the camp, were (in descending order of frequency): cooperative attitude of medical care staff in general medical treatment with the patient and the patient's family (47%); understanding of childhood growth and development (45%); knowledge of childhood asthma (38%); learning of basic medical manner (34%); and mastery of basic techniques for therapy and examination (25%). These findings suggest that a summer camp is useful for exposing undergraduate medical students to children with asthma and is effective for helping them understand patients and family-oriented pediatric medicine.
5.Japan Society of Gynecologic Oncology 2018 guidelines for treatment of uterine body neoplasms
Wataru YAMAGAMI ; Mikio MIKAMI ; Satoru NAGASE ; Tsutomu TABATA ; Yoichi KOBAYASHI ; Masanori KANEUCHI ; Hiroaki KOBAYASHI ; Hidekazu YAMADA ; Kiyoshi HASEGAWA ; Hiroyuki FUJIWARA ; Hidetaka KATABUCHI ; Daisuke AOKI
Journal of Gynecologic Oncology 2020;31(1):18-
6.Japan Society of Gynecologic Oncology 2018 guidelines for treatment of uterine body neoplasms
Wataru YAMAGAMI ; Mikio MIKAMI ; Satoru NAGASE ; Tsutomu TABATA ; Yoichi KOBAYASHI ; Masanori KANEUCHI ; Hiroaki KOBAYASHI ; Hidekazu YAMADA ; Kiyoshi HASEGAWA ; Hiroyuki FUJIWARA ; Hidetaka KATABUCHI ; Daisuke AOKI
Journal of Gynecologic Oncology 2020;31(1):e18-
The Fourth Edition of the Guidelines for Treatment of Uterine Body Neoplasm was published in 2018. These guidelines include 9 chapters: 1. Overview of the guidelines, 2. Initial treatment for endometrial cancer, 3. Postoperative adjuvant therapy for endometrial cancer, 4. Post-treatment surveillance for endometrial cancer, 5. Treatment for advanced or recurrent endometrial cancer, 6. Fertility-sparing therapy, 7. Treatment of uterine carcinosarcoma and uterine sarcoma, 8. Treatment of trophoblastic disease, 9. Document collection; and nine algorithms: 1-3. Initial treatment of endometrial cancer, 4. Postoperative adjuvant treatment for endometrial cancer, 5. Treatment of recurrent endometrial cancer, 6. Fertility-sparing therapy, 7. Treatment for uterine carcinosarcoma, 8. Treatment for uterine sarcoma, 9. Treatment for choriocarcinoma. Each chapter includes overviews and clinical questions, and recommendations, objectives, explanation, and references are provided for each clinical question. This revision has no major changes compared to the 3rd edition, but does have some differences: 1) an explanation of the recommendation decision process and conflict of interest considerations have been added in the overview, 2) nurses, pharmacists and patients participated in creation of the guidelines, in addition to physicians, 3) the approach to evidence collection is listed at the end of the guidelines, and 4) for clinical questions that lack evidence or clinical validation, the opinion of the Guidelines Committee is given as a “Recommendations for tomorrowâ€.